Get the SPI Wire

Artiva Biotherapeutics, Inc.

NASDAQ:ARTV
Annual Meeting

of Shareholders

MEETING DATE

09/08/2026
DEF 14A FILED
08/03/2026
PUBLISHED
08/03/2026 8:08 pm
TIME TO PUBLISH
08/05/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:ARTV · CUSIP 04317A107 · CLASS common stock · CIK 0001817241

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

4
FOR
0
AGAINST
0
WITHHOLD
4
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1.01
Brian Daniels, M.D.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated the incumbent Class II director for election at the Annual Meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1.02
Laura Stoppel, Ph.D.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated the incumbent Class II director for election at the Annual Meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To ratify the appointment by the Audit Committee of the Board of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Audit Committee appointed KPMG LLP and recommended stockholders ratify the selection.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the Plan by 5,097,095 shares and include in the calculation of the share reserve increase shares of common stock issuable upon exercise of convertible pre-funded warrants
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board amended the 2024 Plan, subject to stockholder approval, to increase authorized shares by 5,097,095.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

59057a8e07ac7c6631c9fe6a1e7789c3f0bb2bb2c04827279816d1a25f4a5fb3

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates